Guidelines for the management of lichen sclerosus

British Journal of Dermatology

Volumn 147, Issue 4, 2002, Pages 640-649

  Neill, S M ^a,b,c   Tatnall, F M ^d   Cox, N H ^e  

^a ST PETER S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d WATFORD GENERAL HOSPITAL   (United Kingdom)

^e CUMBERLAND INFIRMARY   (United Kingdom)

Author keywords

Guidelines; Lichen sclerosus

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ANTIPRURITIC AGENT; BETAMETHASONE; CLOBETASOL PROPIONATE; CYCLOSPORIN A; ESTROGEN; OXATOMIDE; PROGESTERONE; PSORALEN; RETINOID DERIVATIVE; STANOZOLOL; TESTOSTERONE;

CANCER RISK; CLINICAL FEATURE; CRYOTHERAPY; DRUG EFFICACY; DYSESTHESIA; FOLLOW UP; GENITAL SYSTEM; HUMAN; INCIDENCE; LICHEN SCLEROSUS ET ATROPHICUS; LOW LEVEL LASER THERAPY; MEDICAL SOCIETY; PATHOGENESIS; PATIENT COMPLIANCE; PHIMOSIS; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOCYST; PSYCHOSEXUAL DISORDER; REVIEW; SCAR FORMATION; SQUAMOUS CELL CARCINOMA; STENOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VIRILIZATION; VULVODYNIA;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; LONG-TERM CARE; MALE; TREATMENT FAILURE;

EID: 0036405032     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.05012.x     Document Type: Review

References (86)

1. Hallopeau H. Leçons clinique sur les maladies cutanées et syphilitique. Union Med 1887; 43: 742-7.
2. Hallopeau H. Lichen plan sclereux. Ann Dermatol Syph 1889; 10: 447-9.
3. Darier J. Lichen plan sclereux. Ann Dermatol Syph 1892; 3: 833-7.
4. Breisky D. Über Kraurosis vulvae. Z Heilkd 1885; 6: 69-80.
5. Clarke J, Etherington IJ, Luesley D. Response of vulvar lichen sclerosus and squamous cell hyperplasia to graduated topical steroids. J Reprod Med 1999; 44: 958-62.
6. Dickie RJ, Horne CHW, Sutherland HW. Direct evidence of localized immunologic damage in lichen sclerosus et atrophicus. J Clin Pathol 1982; 35: 1395-9.
7. Carli P, Cattaneo A, Pimpenelli N et al. Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991; 182: 18-22.
8. Farrell AM, Marren P, Dean D, Wojnarowska F. Lichen sclerosus: Evidence that immunological changes occur at all levels of the skin. Br J Dermatol 1999; 140: 1087-92.
9. Goolamali SK, Barnes EW, Irvine WJ, Shuster S. Organ specific antibodies in patients with lichen sclerosus. Br Med J 1974; iv: 78-9.
10. Harrington CI, Dunsmore IR. An investigation into the incidence of autoimmune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981; 104: 563-6.
11. Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus atrophicus and autoimmune related disease in males. Br J Dermatol 1983; 109: 661-4.
12. Marren P, Charnock FM, Bunce M et al. The associations between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132: 197-203.
13. Azurdia RM, Luzzi GA, Byren L et al. Lichen sclerosus in adult men: A study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol 1999; 140: 79-83.
14. Powell J, Wojnarowska F, Winsey S et al. Lichen sclerosus premenarche: Autoimmunity and immunogenetics. Br J Dermatol 2000; 142: 481-4.
15. De Vito JR, Merogi AJ, Vo T et al. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: A PCR study of thirty five cases. J Cutan Pathol 1996; 23: 350-8.
16. Fujiwara H, Fujiwara K, Hashimoto K et al. Detection of Borrelia burgdoferi DNA (B. garinii or B. afzelii) in morphoea and lichen sclerosus et atrophicus tissue of German and Japanese but not of US patients. Arch Dermatol 1997; 133: 41-4.
17. Wallace HJ. Lichen sclerosus et atrophicus. Trans St John's Dermatol Soc 1971; 57: 9-30.
18. Ridley CM. Genital lichen sclerosus (lichen sclerosus et atrophicus) in childhood and adolescence. J R Soc Med 1993; 86: 69-75.
19. Lipscombe TK, Wayte J, Wojnarowska F et al. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol 1997; 38: 132-6.
20. Handfield Jones SE, Hinde FR, Kennedy CTC. Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. Br Med J 1987; 294: 1404-5.
21. Warrington S, San Lazaro C. Lichen sclerosus and sexual abuse. Arch Dis Child 1996; 75: 512-16.
22. Aynaud O, Piron D, Casanova JM. Incidence of preputial lichen sclerosus in adults: Histologic study of circumcision specimens. J Am Acad Dermatol 1999; 41: 923-6.
23. Liatsikos EN, Perimenis P, Dandinis K et al. Lichen sclerosus et atrophicus. Findings after complete circumcision. Scand J Urol Nephrol 1997; 31: 453-6.
24. Chalmers RJ, Burton PA, Bennett RF et al. Lichen sclerosus et atrophicus. A common and distinctive cause of phimosis in boys. Arch Dermatol 1984; 120: 1025-7.
25. Meuli M, Briner J, Hanimann B. Lichen sclerosus et atrophicus causing phimosis in boys: A prospective study with 5-year follow up after complete circumcision. J Urol 1994; 152: 987-9.
26. Brown AR, Dunlap CL, Bussard DA, Lask JT. Lichen sclerosus et atrophicus of the oral cavity: report of two cases. Oral Surg Oral Pathol Oral Radiol Endod 1997; 84: 165-70.
27. Hewitt J. Histologic criteria for lichen sclerosus of the vulva. J Reprod Med 1986; 31: 781-7.
28. Marren P, Millard PR, Wojnarowska F. Vulval lichen sclerosus: Lack of correlation between duration of clinical symptoms and histological appearances. J Eur Acad Dermatol Venereol 1997; 8: 212-16.
29. Brisgotti M, Moreno A, Murcia C et al. Verrucous carcinoma of the vulva. A clinicopathologic and immunohistochemical study of 5 cases. Int J Gynecol Pathol 1989; 8: 1-7.
30. Derrick EK, Ridley CM, Kobza-Black A et al. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol 2000; 143: 1217-23.
31. Meyrick Thomas RH, McGibbon DH, Munro DD. Basal cell carcinoma of the vulva in association with vulval lichen sclerosus et atrophicus. J R Soc Med 1985; 78: 16-18.
32. Friedman RJ, Kopf AW, Jones WB. Malignant melanoma in association with lichen sclerosus on the vulva of a 14 year old. Am J Dermatopathol 1984; 6 (Suppl. 1): 253-6.
33. Egan CA, Bradley RR, Logsdon VK et al. Vulvar melanoma in childhood. Arch Dermatol 1997; 133: 345-8.
34. Carli P, Cattaneo A, De Magnis A et al. Squamous cell carcinoma arising in lichen sclerosus: A longitudinal cohort study. Eur J Cancer Prevention 1995; 4: 491-5.
35. Hart WR, Norris HJ, Helwig EB. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975; 45: 369-77.
36. Leibowitch M, Neill S, Pelisse M, Moyal Barracco M. The epithelial changes associated with squamous cell carcinoma of the vulva: A review of the clinical, histologic and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97: 1135-9.
37. Walkden V, Chia Y, Wojnarowska F. The association of squamous cell carcinoma and lichen sclerosus; implications for follow up. J Obstet Gynecol 1997; 17: 551-3.
38. Vilmer C, Cavelier-Balloy B, Nogues C et al. Analysis of alterations adjacent to invasive vulvar cancer and their relationship with the associated carcinoma: A study of 67 cases. Eur J Gynecol Oncol 1998; 19: 25-31.
39. Crum CP, McLachlin CM, Tate JE, Mutter GL. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol 1997; 9: 63-9.
40. Kiene P, Milde-Langosch K, Löning T. Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus. Arch Dermatol Res 1991; 283: 445-8.
41. Hacker NF, van der Velden J. Conservative management of early vulvar cancer. Cancer 1993; 71: 1673-7.
42. Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol 1999; 41: 911-14.
43. Powell J, Robson A, Cranston D et al. High incidence of lichen sclerosus in patients with squamous cell carcinoma of the penis. Br J Dermatol 2001; 145: 85-9.
44. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995; 32: 393-412.
45. Drut RM, Gomez MA, Biology L et al. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: An in situ hybridisation and SP-PCR study. Pediatr Dermatol 1998; 15: 85-90.
46. Dahlman-Ghozlan K, von Hedblad MA, Krogh G. Penile lichen sclerosus treated with clobetasol dipropionate 0.05% cream: A retrospective clinical and histopathological study. J Am Acad Dermatol 1999; 40: 451-7.
47. Cupp MR, Malek RS, Goellner JR et al. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995; 154: 1024-9.
48. Lau PW, Cook N, Andrews H et al. Detection of human papillomavirus types in balanitis xerotica obliterans and other penile conditions. Genitourin Med 1995; 71: 228-30.
49. Rouzier R, Haddad B, Deyrolle C et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol 2002; 186: 49-52.
50. Paniel B. Surgical procedures in benign vulval disease. In: The Vulva (Ridley CM, Neill SM, eds). Oxford: Blackwell Science, 1999; 288-90.
51. Dalziel K. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995; 40: 351-4.
52. Marin MG, King R, Dennerstein GJ, Sfameni S. Dyspareunia and vulval disease. J Reprod Med 1998; 43: 952-8.
53. Dalziel K, Millard PR, Wojnarowska F. The treatment of vulvar lichen sclerosus with a very potent topical corticosteroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991; 124: 461-4.
54. Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998; 43: 790-4.
55. Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: An overview. Br J Dermatol 1998; 139: 763-6.
56. Riddell L, Edwards A, Sherrard J. Clinical features of lichen sclerosus in men attending a department of genitourinary medicine. Sex Transm Infect 2000; 76: 311-13.
57. Fischer G, Rogers M. Treatment of childhood vulval lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 1997; 14: 235-8.
58. Garzon MC, Paller AS. Ultrapotent topical corticosteroid treatment of childhood lichen sclerosus. Arch Dermatol 1999; 135: 525-8.
59. Wright JE. The treatment of childhood phimosis with topical steroid. Aust NZ J Surg 1994; 64: 327-8.
60. Lindhagen T. Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin. Eur J Surg 1996; 162: 969-72.
61. Jørgensen ET, Svensson Å. The treatment of phimosis in boys, with a potent topical steroid (clobetasol propionate 0.05%) cream. Acta Derm Venereol (Stockh) 1993; 73: 55-6.
62. Friedrich EG Jr. Topical testosterone for benign vulvar dystrophy. Obstet Gynecol 1971; 37: 677-86.
63. Zelle K. Treatment of vulvar dystrophies with topical testosterone propionate. Am J Obstet Gynecol 1971; 109: 570-3.
64. Skierlo P, Heise H. Testosterone propionate ointment-A therapeutic trial in lichen sclerosus et atrophicus. Hautarzt 1987; 38: 295-7.
65. Bornstein J, Heifetz S, Kellner Y et al. Clobetasol dipropionate 0.05% versus testosterone 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998; 178: 80-4.
66. Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynecol Obstet 1994; 46: 53-6.
67. Cattaneo A, Carli P, De Marco A et al. Testosterone maintenance therapy. Effects on vulval lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996; 41: 99-102.
68. Clifton MM, Bayer Garner IB, Kohler S, Smoller B. Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: Evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol 1999; 41: 43-6.
69. Jasionowski EA, Jasionowski PA. Further observations of the effect of topical progesterone on vulvar disease. Am J Obstet Gynecol 1979; 134: 565-7.
70. Pasieczny TA. The treatment of balanitis xerotica obliterans with testosterone propionate ointment. Acta Derm Venereol (Stockh) 1977; 57: 275-7.
71. Lascano EF, Montes LF, Mazzini MA. Tissue changes in lichen sclerosus in children following local application of oestrogens. Br J Dermatol 1964; 76: 496-7.
72. August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol 1980; 103: 667-70.
73. Hillemans P, Untch M, Prove F et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999; 93: 71-4.
74. Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997; 136: 356-9.
75. Khezri AA, Dounis A, Dunn M. Balanitis xerotica obliterans. Br J Urol 1979; 51: 229-31.
76. Campus GV, Ena P, Scuderi N. Surgical treatment of balanitis xerotica obliterans. Plast Reconstr Surg 1984; 73: 652-7.
77. Hrebinko RL. Circumferential laser vaporization for severe meatal stenosis secondary to balanitis xerotica obliterans. J Urol 1996; 156: 1735-6.
78. Klein LE, Cohen SR, Weinstein M. Bullous lichen sclerosus et atrophicus: Treatment by tangential excision. J Am Acad Dermatol 1984; 10: 346-50.
79. Kreuter A, Jansen T, Stucker M et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26: 30-2.
80. Carli P, Cattaneo A, Taddei G, Gianotti B. Topical cyclosporine in the treatment of vulvar lichen sclerosus: Clinical, histologic and immunohistochemical findings. Arch Dermatol 1992; 128: 1548-9.
81. Mork N-J, Jensen P, Hoel PS. Vulval lichen sclerosus treated with etretinate (Tigason). Acta Derm Venereol (Stockh) 1986; 66: 363-5.
82. Bousema MT, Romppanen U, Geiger J-M et al. Acitretin in the treatment of lichen sclerosus et atrophicus of the vulva: A double blind placebo controlled study. J Am Acad Dermatol 1994; 30: 225-31.
83. Virgili A, Corazza M, Bianchi A et al. Open study of topical 0.025% tretinoin in the treatment of vulval lichen sclerosus. One year of therapy. J Reprod Med 1995; 40: 614-18.
84. Penneys NS. Treatment of lichen sclerosus with potassium paraaminobenzoate. J Am Acad Dermatol 1984; 10: 1039-42.
85. Parsad D, Saini R. Oral stanozolol in lichen sclerosus et atrophicus. J Am Acad Dermatol 1998; 38: 278-9.
86. Griffiths CEM. The British Association of Dermatologists guidelines for the management of skin disease. Br J Dermatol 1999; 141: 396-7.